足月胎膜早破后引产的最佳时机:TERMPROM研究的二次分析
该研究为TERMPROM随机临床试验的二次分析,纳入4742例足月胎膜早破孕妇,按1小时间隔比较引产与期待管理。结果显示,胎膜早破后15至20小时内引产可降低新生儿感染复合结局、新生儿重症监护病房入住和母体感染风险,且不增加剖宫产风险。
要点
- 胎膜早破后15至20小时内引产可降低新生儿感染复合结局、新生儿重症监护病房入住和母体感染风险,不增加剖宫产。
- 胎膜早破后30至36小时内引产者破膜至分娩时间更短、母体总住院时间更短。
- 期待管理组中仅64%(1365/2120)在破膜后24小时内自然临产。
核心结论
- 研究提示,足月胎膜早破后立即引产似乎是减少新生儿和母体发病的最佳管理策略。
- 若立即引产不可行,在胎膜早破后15至20小时内引产仍优于期待管理。
研究设计与样本
- TERMPROM试验的二次分析,该试验为国际多中心随机临床试验,比较足月(≥37+0/7周)胎膜早破孕妇立即分娩与期待管理。
- 将所有参与者视为足月胎膜早破单一队列,不考虑原随机分组。
- 在胎膜早破后36小时内每个1小时间隔,比较该间隔内开始引产者与同期期待管理者的结局。
- 共纳入4742例符合标准者,其中2622例接受引产,2120例自然临产。
主要发现
- 新生儿复合结局、新生儿重症监护病房入住和母体感染率随胎膜早破后时间延长而逐渐升高。
- 胎膜早破后15至20小时内引产者上述结局风险低于同期期待管理者,且不增加剖宫产风险。
- 胎膜早破后30至36小时内引产者破膜至分娩时间及母体总住院时间均短于同期期待管理者。
- 期待管理组中64%(1365/2120)在破膜后24小时内自然临产。
临床怎么用
- 作者认为,足月胎膜早破后立即引产似乎是减少新生儿和母体发病的最佳管理策略。
- 作者认为,若立即引产不可行,在胎膜早破后15至20小时内引产仍优于期待管理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In the case of prelabor rupture of membranes at term, the risk for neonatal and maternal infectious morbidity increases progressively with time from prelabor rupture of membranes. Although most studies identified a benefit associated with early induction within the first 24 hours following term prelabor rupture of membranes, there is currently no precise data regarding how early should induction be scheduled. OBJECTIVE: This study aimed to identify the optimal timing of labor induction among women with term prelabor rupture of membranes by comparing the maternal and neonatal outcomes associated with labor induction with those of expectant management at any given 1-hour interval following prelabor rupture of membranes. STUDY DESIGN: This was a secondary analysis of data from the TERMPROM trial, an international, multicenter, randomized clinical trial on immediate delivery vs expectant management of women with prelaor rupture of membranes at term (≥37+0/7 weeks' gestation). We considered all participants as a single cohort of women with term prelabor rupture of membranes, irrespective of the original randomized study group allocation. For each given 1-hour time interval within the first 36 hours following prelabor rupture of membranes, we compared the outcomes of subjects for whom labor induction was initiated during this interval with those of subjects managed expectantly at the same time interval. The primary neonatal outcome was a composite of neonatal infection and admission to the neonatal intensive care unit. The primary maternal outcomes included maternal infection (clinical chorioamnionitis or postpartum fever) and cesarean delivery. RESULTS: Of the 4742 subjects who met the study criteria, 2622 underwent labor induction, and 2120 experienced a spontaneous onset of labor. The rates of the neonatal composite outcome, neonatal admission to intensive care unit, and maternal infection increased progressively with time after prelabor rupture of membranes. The risk for these outcomes was lower among women who underwent induction when compared with those managed expectantly within the first 15 to 20 hours after prelabor rupture of membranes without affecting the risk for cesarean delivery. In addition, women who underwent labor induction within the first 30 to 36 hours had a shorter prelabor rupture of membranes to delivery time and a shorter total maternal hospital stay when compared with those managed expectantly at the same time interval. Among women managed expectantly, less than two-thirds (64%; 1365/2120) experienced a spontaneous onset of labor within the first 24 hours following prelabor rupture of membranes. CONCLUSION: These findings suggest that immediate labor induction seems to be the optimal management strategy to minimize neonatal and maternal morbidity in the setting of prelabor rupture of membranes at term gestations. In cases for which immediate induction is not feasible, labor induction remains the preferred option over expectant management if performed within the first 15 to 20 hours after prelabor rupture of membranes.
引用
- Melamed N, Berghella V, Ananth CV, et al. Optimal timing of labor induction after prelabor rupture of membranes at term: a secondary analysis of the TERMPROM study. Am J Obstet Gynecol. 2022. PMID: 36116523. doi:10.1016/j.ajog.2022.09.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。